The infertility treatment market is primarily driven by factors such as the declining fertility rate, rising number of fertility clinics worldwide, technological advancements, and increasing public-private investments, funds, and grants. However, the high procedural costs of assisted reproductive technology procedures in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.
During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.
Infertility treatment Market Dynamics :-
1. Driver: Declining fertility rate
2. Restraint: High costs associated with assisted reproductive technology in developed markets
3. Opportunity: Emerging markets in APAC and RoW
4. Challenge: Concerns related to ART procedures
In order to monitor activities related to ART procedures, strict regulations have been formulated by authorities in various countries across the globe. Authorities such as the International Federation of Fertility Societies (IFFS), European Society of Human Reproduction and Embryology (ESHRE), Indian Council of Medical Research (ICMR), Ethics Committee of American Society for Reproductive Medicine (ASRM), and Human Fertilization and Embryology Authority (HFEA) have implemented stringent regulations for infertility treatment.
Download PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112
Leading Key Players Operating in the Infertility Treatment Market Includes:
The prominent players operating in the global infertility treatment market include The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US).
Asia Pacific dominates the infertility treatment market. Significant rise in the medical tourism, Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing rate of infertility in the region, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.
Primary and Secondary Research Methodology For Infertility Treatment :-
The infertility treatment market comprises several stakeholders such as manufacturers Of infertility treatment equipment, media & consumables, and accessories market research and consulting firms. The demand side of this market is characterized by the rise in number of fertility clinics, decline in fertility rates, presence of well established players in the market.
In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources such as World Health Organization (WHO), World Bank, Human Fertilization and Embryology Authority (HFEA), International Federation of Fertility Societies (IFFS).